Screener
Paysign PAYS Q2 2026 earnings
Reported August 5, 2026 · After market close
Revenue$28.3MBeat by $1.9M
EPS$0.11Beat by $0.05
Revenue estimate$26.4M
EPS estimate$0.06
“Paysign delivered a strong second quarter, achieving record revenue, net income, and adjusted EBITDA while continuing to expand margins. Strong growth in our patient affordability business, steady performance in plasma donor compensation, and disciplined execution across the company drove meaningful operating leverage and profitability, reinforcing the multiyear strategy we have been building. With momentum across the business and a robust pipeline of opportunities, we intend to remain focused on sustainable growth, continued margin expansion, and creating long-term value for shareholders.”
Next report
Nov 11, 2026 (in 2 months)Revenue estimate$29.0M
EPS estimate$0.09
Segments
By product
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Paysign report Q2 2026 earnings?
- Paysign (PAYS) reported Q2 2026 earnings on August 5, 2026 after market close.
- What were Paysign's Q2 2026 revenue and EPS?
- Paysign reported revenue of $28.3M and eps of $0.11 for Q2 2026.
- Did Paysign beat estimates in Q2 2026?
- Revenue beat the consensus estimate of $26.4M by $1.9M. EPS beat the consensus estimate of $0.06 by $0.05.
- How did Paysign's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 48.1% from $19.1M a year earlier and eps grew 450.0% from $0.02.
- Where can I find Paysign's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001683168-26-005988) and the 10-Q periodic report (0001683168-26-006021) directly on SEC EDGAR. The filing index links above go to sec.gov.
